Viewing Study NCT05342792


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-01-02 @ 1:19 AM
Study NCT ID: NCT05342792
Status: RECRUITING
Last Update Posted: 2022-04-25
First Post: 2022-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module